ArticleJournal of the Chinese Medical Association : JCMA2025

BBB-penetrant tyrosine kinase inhibitor plus intracranial radiotherapy vs BBB-penetrant TKI alone in Asians with EGFR-mutated lung adenocarcinoma and brain metastases.

You-Cong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.